120 related articles for article (PubMed ID: 37307530)
1. Expression of angiogenic and lymphangiogenic genes in primary cutaneous melanoma: relationship with angiolymphatic invasion and disease-free survival.
García-Pérez O; Melgar-Vilaplana L; Sifaoui I; García-Bello MÁ; Córdoba-Lanús E; Fernández-de-Misa R
Melanoma Res; 2023 Oct; 33(5):375-387. PubMed ID: 37307530
[TBL] [Abstract][Full Text] [Related]
2. VEGFC Gene Expression Is Associated with Tumor Progression and Disease-Free Survival in Cutaneous Squamous Cell Carcinoma.
García-Pérez O; Melgar-Vilaplana L; Sifaoui I; Śmietańska A; Córdoba-Lanús E; Fernández-de-Misa R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203550
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
4. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
[TBL] [Abstract][Full Text] [Related]
5. Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease.
Ji YW; Lee JL; Kang HG; Gu N; Byun H; Yeo A; Noh H; Kim S; Choi EY; Song JS; Lee HK
Ocul Surf; 2018 Jul; 16(3):306-313. PubMed ID: 29601983
[TBL] [Abstract][Full Text] [Related]
6. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.
Park JY; Amankwah EK; Anic GM; Lin HY; Walls B; Park H; Krebs K; Madden M; Maddox K; Marzban S; Fang S; Chen W; Lee JE; Wei Q; Amos CI; Messina JL; Sondak VK; Sellers TA; Egan KM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):827-34. PubMed ID: 23462921
[TBL] [Abstract][Full Text] [Related]
7. Survival prediction in patients with cutaneous melanoma by tumour lymphangiogenesis.
Špirić Z; Vještica M; Erić M
Acta Clin Belg; 2020 Dec; 75(6):379-387. PubMed ID: 31210586
[No Abstract] [Full Text] [Related]
8. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma.
Rossi M; Tuck J; Kim OJ; Panova I; Symanowski JT; Mahalingam M; Riker AI; Alani RM; Ryu B
Br J Dermatol; 2014 Aug; 171(2):403-8. PubMed ID: 24359286
[TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression.
Wang M; Xu Y; Wen GZ; Wang Q; Yuan SM
Onco Targets Ther; 2019; 12():4643-4654. PubMed ID: 31354297
[No Abstract] [Full Text] [Related]
12. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
13. VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.
Patten SG; Adamcic U; Lacombe K; Minhas K; Skowronski K; Coomber BL
BMC Cancer; 2010 Dec; 10():683. PubMed ID: 21159176
[TBL] [Abstract][Full Text] [Related]
14. MET expression in melanoma correlates with a lymphangiogenic phenotype.
Swoboda A; Schanab O; Tauber S; Bilban M; Berger W; Petzelbauer P; Mikula M
Hum Mol Genet; 2012 Aug; 21(15):3387-96. PubMed ID: 22570180
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.
Pastushenko I; Vermeulen PB; Vicente-Arregui S; Van den Eynden GG; Alvarez-Alegret R; Querol I; Rutten A; Carapeto FJ; Dirix LY; Van Laere S
J Cutan Pathol; 2015 Oct; 42(10):699-711. PubMed ID: 26264662
[TBL] [Abstract][Full Text] [Related]
16. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
18. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
